When was S3V Vascular Technologies founded?

S3V Vascular Technologies was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is S3V Vascular Technologies located?

S3V Vascular Technologies is headquartered in Mysuru, India. It is registered at Plot No. 65/D4, Hootagalli Industrial Area Hootagalli, Mysore, Mysuru, Karnataka, India, 570018.

Which legal entities is S3V Vascular Technologies associated with?

S3V Vascular Technologies is associated with S3v Vascular Technologies Limited.

How many employees does S3V Vascular Technologies have?

As of Aug 31, 2025, S3V Vascular Technologies has 81 employees, reflecting a 46% year-over-year decline in headcount.

Is S3V Vascular Technologies a funded company?

S3V Vascular Technologies is a funded company, having raised a total of $41.9M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 05, 2012.

How much is S3V Vascular Technologies worth?

The latest valuation of S3V Vascular Technologies is $***** as of Mar 26, 2024.

When was the latest funding round of S3V Vascular Technologies?

S3V Vascular Technologies' latest funding was a $***** Series B round on Mar 13, 2024, with participation from 23 investors.

What is the annual revenue of S3V Vascular Technologies?

Annual revenue of S3V Vascular Technologies is between ₹10 Cr and ₹50 Cr as on Mar 31, 2025

Where does S3V Vascular Technologies rank among its competitors?

S3V Vascular Technologies ranks 3rd amongst 12 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Global Vascular, which secured $6.91M in Jun, 2025.

Who are the top competitors of S3V Vascular Technologies?

S3V Vascular Technologies' top competitors include Lifetech Scientific Corporation, REVA Medical and Integris Medtech. Among them, Global Vascular secured the most recent funding round in June, 2025.

S3V Vascular Technologies - 2026 Company Profile, Team, Funding, Competitors & Financials

S3V Vascular Technologies is a series B company based in Mysuru (India), founded in 2011 by Badari Narayan Nagarada Gadde. It operates as a Developer of cardiovascular surgical and critical care devices. S3V Vascular Technologies has raised $41.9M in funding from Vivamed Technologies, with a current valuation of $*****. The company has 12 active competitors, including 4 funded and 4 that have exited. Its top competitors include companies like Lifetech Scientific Corporation, REVA Medical and Integris Medtech.

Company Details

Developer of cardiovascular surgical and critical care devices. It has a lead product 3V SIRIS rapamycin eluting coronary stent implantation system with unique Inert Stent Platform. It also offers cardiac stents, clot retrievers, and catheters such as coronary stent implantation system, drug eluting stent system, aspiration catheter, and balloon dilatation catheter.

Website: s3vvascular.com
Social
Email ID: *****@s3vvascular.com
Registered Address: Plot No. 65/D4, Hootagalli Industrial Area Hootagalli, Mysore, Mysuru, Karnataka, India, 570018

Key Metrics

Founded Year

2011

Location

Mysuru, India

Stage

Series B

Total Funding

$41.9M in 8 rounds

Latest Funding Round

Series B, Mar 13, 2024, $*****

Post Money Valuation

$***** as on Mar 26, 2024

Investors

Narendra Srisrimal & 152 more

Ranked

3^rd among 12 active competitors

Annual Revenue

₹10 - ₹50 Cr as on Mar 31, 2025

Employee Count

81 as on Aug 31, 2025

Similar Companies

Integris Medtech & 7 more

View S3V Vascular Technologies' full profile

S3V Vascular Technologies is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
S3v Vascular Technologies Limited CIN: U33112KA2011PLC059915 , India, Active	Aug 09, 2011	₹10 - ₹50 Cr (As on Mar 31, 2025)	82 (As on Mar 01, 2026)

S3V Vascular Technologies has raised a total funding of $41.9M over 8 rounds. Its first funding round was on Dec 05, 2012. Its latest funding round was a Series B round on Mar 13, 2024 for $*****. 23 investors participated in its latest round. S3V Vascular Technologies has 22 institutional investors and 131 angel investors.

Here is the list of recent funding rounds of S3V Vascular Technologies:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 13, 2024	2979676	Series B	6459927	7285893	2051721	4844977
Feb 09, 2023	9711026	Series A	2542118	4325154	9586821	Kaveripakam Kodanda Ramaiah & 7 more
Aug 18, 2021	9373673	Angel	6522124	6758693	Rukmini Badam & 11 more	Padma Bejgam

Access funding benchmarks and valuations. Sign up today!

View details of S3V Vascular Technologies's funding rounds and investors

The founders of S3V Vascular Technologies is Badari Narayan Nagarada Gadde.

Here are the details of S3V Vascular Technologies' key team members:

Badari Narayan Nagarada Gadde: Co-Founder & Managing Director of S3V Vascular Technologies. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

S3V Vascular Technologies' Board of Directors

S3V Vascular Technologies's board has 11 active members. Narendra Kumar Srisrimal, Badari Narayan Nagarada Gadde, Dip Kishore, Veeresham Ciddi, Venkateswara Gowtama Mannava, Vijaya Gopal Nagaradagadde and Govindan Ramaswamy are part of team and Chandragupta Vijayraj Jain, Narayan Kalindhi, Nagarada Gadde Vishnu Shreyas and Prithi Sureka Mummidi are independent board members.

Here is the list of S3V Vascular Technologies' board of directors:

Name	Type	Representing	Status	Duration
Vijaya Gopal Nagaradagadde	Team	-	Current	15y 2m
sinfitj	Team	-	Past	1y 1m
acla{ka	Team	-	Past	7y 3m
chagpxj	Team	-	Past	8y 1m
pymctgq	Team	-	Past	3y 5m
Veeresham Ciddi	Investor	-	Current	4y 5m
Govindan Ramaswamy	Investor	-	Current	2y 6m
rzepfpq	Investor	-	Past	7y 7m
bxmhehm	Investor	-	Past	4y 7m
brpvdhe	Investor	-	Past	8y 2m
Chandragupta Vijayraj Jain	Independent board member	-	Current	6y 10m
iucmxru	Independent board member	-	Current	5y 6m
qlrvsle	Independent board member	-	Current	5y 6m
vlbgkix	Independent board member	-	Past	1y 6m
pxlrvae	Independent board member	-	Past	5y 2m

View details of S3V Vascular Technologies's Founder profiles and Board Members

S3V Vascular Technologies' employee count trend

S3V Vascular Technologies has 81 employees as of Aug 25. The total employee count is 47.0% lower than what it was in Aug 24. Here is S3V Vascular Technologies's employee count trend over the years:

Employee count trend for S3V Vascular Technologies

Uncover S3V Vascular Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of S3V Vascular Technologies include Lifetech Scientific Corporation, REVA Medical and Integris Medtech. Here is the list of Top 10 competitors of S3V Vascular Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lifetech Scientific Corporation 1999, Shenzhen (China), Public	Interventional medical devices to treat cardiovascular and peripheral vascular diseases.	$66.2M	Medtronic, Ally Bridge Group & 2 others	59/100
2nd	REVA Medical 1998, San Diego (United States), Public	Developer of Balloon-expandable and bioresorbable drug-eluting stent	$42M	Brookside Capital, Cerberus Capital Management ... & 9 others	59/100
3rd	S3V Vascular Technologies 2011, Mysuru (India), Series B	Developer of cardiovascular surgical and critical care devices	$41.9M	Larsen Toubro, Mahima Stocks & 151 others	55/100
4th	Integris Medtech 2008, Gurugram (India), Seed	Manufacturer of cardiovascular medical devices and clinical laboratory diagnostic solutions	-	India SME Investments & 1 others	47/100
5th	Medinol 1992, Tel Aviv (Israel), Acquired	Coronary stenting system	-	Pitango, Boston Scientific	38/100
6th	iVascular 2010, Barcelona (Spain), Unfunded	Catheter and stent manufacturer for cardiovascular procedures	-	-	37/100
7th	Global Vascular 2022, Tokyo (Japan), Series B	Developer of drug eluting stent delivery system for lower limb artery disease	$7.97M	Tokyo University of Science Innovation Capital, Mitsubishi UFJ Capital ... & 8 others	36/100
8th	Elixir Medical 2005, Sunnyvale (United States), Series A	Drug eluting stents	$5.3M	Invus	28/100
9th	Exon Therapeutics 2023, Surat (India), Unfunded	Manufacturer of drug-coated stents and cardiovascular devices	-	-	26/100
10th	Japan Medical Device Technology 2014, Kumamoto (Japan), Acquired	Developer of magnesium alloy stents for heart disease treatment	-	-	23/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on S3V Vascular Technologies's competitors? Click here to see the top ones

S3v Vascular Technologies Limited, the legal entity associated with S3V Vascular Technologies, generated between ₹10 Cr and ₹50 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of S3v Vascular Technologies Limited has a compounded annual growth rate (CAGR) of 5% in the last 1 year.

Financial Statement Summary

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income Statement
Revenue	9829	2048	7677	4903	5985
Total Sales	5765	9747	7746	2243	1148
Total Expenses	3706	1704	5632	6906	5304
Operating Expenses	6452	8809	1615	6296	4613
Employee Expenses	8491	5835	6996	4701	2875
Marketing Expenses	2067	8241	7480	4943	5944
Operating Income (EBIT)	5439	6398	7712	8084	5712
Interest Expenses	6295	6405	3368	3466	4034
Expenses from other activities	3472	7603	3389	6605	9377
Information Technology Expenses	7066	8370	5569	1032	2025
EBITDA	8472	2010	6764	8283	9164
Taxes	2351	5694	2984	6273	2040
Net Profit	9326	2847	7715	5759	3921
Balance Sheet
Assets	5539	3151	1871	8639	4923
Cash Equivalent	1873	6782	2341	9542	9659
Accounts Receivables	5896	1892	9206	8046	6102
Inventory	6066	3889	9842	4918	4661
Liabilities	9055	7275	1379	9610	9880
Total Debt	4446	5104	4924	1056	6945
Accounts Payable	9682	4724	4633	8591	8962
Equities	2944	1401	3366	3227	9715
Cashflow Statement
Cash from Operating activities	4357	1380	3671	2023	9699
Cash from Investing activities	5107	4818	4462	3829	6873
Net cash from Financing activities	4852	1462	9316	5289	4710

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Founders (largest shareholder) own 38.49%, Funds own 8.17%, Enterprises own 10.92% and Angels own 31.81%. The net worth of S3V Vascular Technologies's founders is INR 130Cr as of Mar 26, 2024. The cap table displayed below is for S3v Vascular Technologies Limited which is the legal entity associated with S3V Vascular Technologies.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	38.49%	130Cr	6148450	1818660	4790891	2142239
Badari Narayan Nagarada Gadde	3085073	9788547	6691908	3134355	2220362	2893034
Fund	8.17%	27.6Cr	1340664	9990501	4742059	1354289
Enterprise	10.92%	36.9Cr	2176366	5521407	5635317	6700626
Angel	31.81%	107Cr	5937626	2342428	6016017	8783691
Narendra Srisrimal	0	0	0	0	0	0
Rajasekhara Chakravarthy	0	0	0	0	0	0
Vipul Chandra	0	0	0	0	0	0
Padma Bangarugadda	0	0	0	0	0	0
Harsh Dhadda	0	0	0	0	0	0
Rukmini Badam	0	0	0	0	0	0
Myadam Padma	0	0	0	0	0	0
Kaveripakam Kodanda Ramaiah	0	0	0	0	0	0
Other People	0.61%	2.07Cr	0	0	0	0
Other Investors	9.99%	33.7Cr	9250265	5152663	5379818	5790694
Total	100.00%	338Cr	4375453	5673466	1805041	4363999